Correction to: British Journal of Cancer (2014) 110, 1525–1534. doi:10.1038/bjc.2014.45
Upon publication of the above paper in British Journal of Cancer, the authors noted that they had omitted KM Matula from the author list. The full and correct author listing is reproduced above.
Change history
01 December 2015
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
Additional information
The online version of the original article can be found at 10.1038/bjc.2014.45
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/
About this article
Cite this article
Bain, G., Collie-Duguid, E., Murray, G. et al. Erratum: Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas. Br J Cancer 113, 1641 (2015). https://doi.org/10.1038/bjc.2015.391
Published:
Issue Date:
DOI: https://doi.org/10.1038/bjc.2015.391
This article is cited by
-
Molecular subtypes in cancers of the gastrointestinal tract
Nature Reviews Gastroenterology & Hepatology (2017)
-
The molecular mechanism of action of superactive human leptin antagonist (SHLA) and quadruple leptin mutein Lan-2 on human ovarian epithelial cell lines
Cancer Chemotherapy and Pharmacology (2016)
